← Back to Search

Airway Clearance Device

OPEP group for Bronchiectasis

N/A
Waitlist Available
Led By Mark Jennings, MD
Research Sponsored by Hill-Rom
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Radiological diagnosis of Bronchiectasis based on high resolution chest CT scan
History of at least 2 acute exacerbations or hospitalizations in the past 12 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial will compare two treatments for bronchiectasis not caused by cystic fibrosis: OPEP and HFCWO.

Eligible Conditions
  • Bronchiectasis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Frequency of acute exacerbations of bronchiectasis
Secondary outcome measures
6-minute walk test
Inflammation - measured by sputum neutrophil elastase level
Mean adherence to prescribed treatment regimen
+10 more

Trial Design

2Treatment groups
Active Control
Group I: OPEP groupActive Control1 Intervention
Subjects in this arm of treatment will use the Acapella® as their primary airway clearance modality for the duration of the study.
Group II: HFCWO groupActive Control1 Intervention
Subjects in this arm of treatment will use The Vest® as their primary airway clearance modality for the duration of the study.

Find a Location

Who is running the clinical trial?

Hill-RomLead Sponsor
33 Previous Clinical Trials
2,799 Total Patients Enrolled
1 Trials studying Bronchiectasis
Mark Jennings, MDPrincipal InvestigatorJohns Hopkins University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~13 spots leftby Mar 2025